Literature DB >> 30341459

The dopamine, serotonin and norepinephrine releasing activities of a series of methcathinone analogs in male rat brain synaptosomes.

Bruce E Blough1, Ann M Decker2, Antonio Landavazo2, Ojas A Namjoshi2, John S Partilla3, Michael H Baumann3, Richard B Rothman3.   

Abstract

RATIONALE: Novel synthetic "bath salt" cathinones continue to appear on the street as abused and addictive drugs. The range of subjective experiences produced by different cathinones suggests that some compounds have primarily dopaminergic activity (possible stimulants) while others have primarily serotonergic activity (possible empathogenics). An understanding of the structure activity relationships (SARs) of these compounds will help in assessing the likely behavioral effects of future novel structures, and to define potential therapeutic strategies to reverse any reinforcing effects.
OBJECTIVES: A series of methcathinone analogs was systematically studied for their activity at the dopamine and serotonin transporters. Compound structures varied at the aromatic group, either by substituent or by replacement of the phenyl ring with a naphthalene or indole ring.
METHODS: A novel, high-yielding synthesis of methcathinone hydrochlorides was developed which avoids isolation of the unstable free bases. Neurotransmitter transporter release activity was determined in rat brain synaptosomes as previously reported. Compounds were also screened for activity at the norepinephrine transporter.
RESULTS: Twenty-eight methcathinone analogs were analyzed and fully characterized in dopamine and serotonin transporter release assays. Compounds substituted at the 2-position (ortho) were primarily dopaminergic. Compounds substituted at the 3-position (meta) were found to be much less dopaminergic, with some substituents favoring serotonergic activity. Compounds substituted at the 4-position (para) were found to be far more serotonergic, as were disubstituted compounds and other large aromatic groups. One exception was the fluoro-substituted analogs which seem to favor the dopamine transporter.
CONCLUSIONS: The dopaminergic to serotonergic ratio can be manipulated by choice of substituent and location on the aromatic ring. It is therefore likely possible to tweak the subjective and reinforcing effects of these compounds by adjusting their structure. Certain substituents like a fluoro group tend to favor the dopamine transporter, while others like a trifluoromethyl group favor the serotonin transporter.

Entities:  

Keywords:  Biogenic amine transporters; Methcathinones; Rat brain synaptosomes; “Bath salts”

Mesh:

Substances:

Year:  2018        PMID: 30341459      PMCID: PMC6475490          DOI: 10.1007/s00213-018-5063-9

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  42 in total

Review 1.  Neurotransmitter transporters in the central nervous system.

Authors:  J Masson; C Sagné; M Hamon; S El Mestikawy
Journal:  Pharmacol Rev       Date:  1999-09       Impact factor: 25.468

Review 2.  Mechanism of action of cathinone: the active ingredient of khat (Catha edulis).

Authors:  N B Patel
Journal:  East Afr Med J       Date:  2000-06

Review 3.  New insights into the mechanism of action of amphetamines.

Authors:  Annette E Fleckenstein; Trent J Volz; Evan L Riddle; James W Gibb; Glen R Hanson
Journal:  Annu Rev Pharmacol Toxicol       Date:  2007       Impact factor: 13.820

4.  Voltage-dependent transient currents of human and rat 5-HT transporters (SERT) are blocked by HEPES and ion channel ligands.

Authors:  Ming Li; Robert A Farley; Henry A Lester
Journal:  FEBS Lett       Date:  2002-02-27       Impact factor: 4.124

Review 5.  Mechanisms of neurotransmitter release by amphetamines: a review.

Authors:  David Sulzer; Mark S Sonders; Nathan W Poulsen; Aurelio Galli
Journal:  Prog Neurobiol       Date:  2005-04       Impact factor: 11.685

6.  Relationship between the serotonergic activity and reinforcing effects of a series of amphetamine analogs.

Authors:  S Wee; K G Anderson; M H Baumann; R B Rothman; B E Blough; W L Woolverton
Journal:  J Pharmacol Exp Ther       Date:  2005-01-26       Impact factor: 4.030

7.  Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin.

Authors:  R B Rothman; M H Baumann; C M Dersch; D V Romero; K C Rice; F I Carroll; J S Partilla
Journal:  Synapse       Date:  2001-01       Impact factor: 2.562

8.  Interaction of the anorectic medication, phendimetrazine, and its metabolites with monoamine transporters in rat brain.

Authors:  Richard B Rothman; Marina Katsnelson; Nga Vu; John S Partilla; Christina M Dersch; Bruce E Blough; Michael H Baumann
Journal:  Eur J Pharmacol       Date:  2002-06-28       Impact factor: 4.432

9.  Evaluation of the reinforcing effects of atomoxetine in monkeys: comparison to methylphenidate and desipramine.

Authors:  Sunmee Wee; William L Woolverton
Journal:  Drug Alcohol Depend       Date:  2004-09-06       Impact factor: 4.492

Review 10.  Dopamine/serotonin releasers as medications for stimulant addictions.

Authors:  Richard B Rothman; Bruce E Blough; Michael H Baumann
Journal:  Prog Brain Res       Date:  2008       Impact factor: 2.453

View more
  4 in total

Review 1.  How preclinical studies have influenced novel psychoactive substance legislation in the UK and Europe.

Authors:  Raquel Santos-Toscano; Amira Guirguis; Colin Davidson
Journal:  Br J Clin Pharmacol       Date:  2020-02-23       Impact factor: 4.335

2.  Locomotor activity and discriminative stimulus effects of five novel synthetic cathinone analogs in mice and rats.

Authors:  Michael B Gatch; Sean B Dolan; Michael J Forster
Journal:  Drug Alcohol Depend       Date:  2019-04-06       Impact factor: 4.492

3.  The Impact of the hAPP695SW Transgene and Associated Amyloid-β Accumulation on Murine Hippocampal Biochemical Pathways.

Authors:  Mona Khorani; Gerd Bobe; Donald G Matthews; Armando Alcazar Magana; Maya Caruso; Nora E Gray; Joseph F Quinn; Jan F Stevens; Amala Soumyanath; Claudia S Maier
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

4.  Four Synthetic Cathinones: 3-Chloromethcathinone, 4-Chloromethcathinone, 4-Fluoro-α-Pyrrolidinopentiophenone, and 4-Methoxy-α-Pyrrolidinopentiophenone Produce Changes in the Spontaneous Locomotor Activity and Motor Performance in Mice with Varied Profiles.

Authors:  Jakub Wojcieszak; Katarzyna Kuczyńska; Jolanta B Zawilska
Journal:  Neurotox Res       Date:  2020-06-06       Impact factor: 3.911

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.